When the Coronavirus first appeared in Wuhan, China late last year, no one expected it to have such a worldwide impact. A little more than two months after the virus started ravaging China, it has spread to most continents, infected more than 150,000 and left at least 9,000 people dead. Naturally, most countries are focused on containment efforts, and one of them is calling on people to maintain high levels of hygiene.

The virus spreads through droplets, and one of the best ways to prevent infection is thorough and constant hand washing. However, with massive numbers of people buying hand sanitizers in bulk, shortages were inevitable.

A Hawaiian cannabis company has stepped in to fill this void by providing free hand sanitizers to its clients. Aloha Green Holdings, which does business as Aloha Green Apothecary, has announced that it will “use its cannabis concentrates production line to produce large quantities of hydroalcoholic gels immediately.”

The cannabis firm operates the largest state of the art cannabis manufacturing lab in Hawaii, and it will use these facilities to manufacture free hand sanitizing gel to 329 card holding patients at its two dispensaries. Regulations require patients to have a 329 card to enter a cannabis retail dispensary.

Each patient will be limited to one 50ml bottle per day until Aloha Green ramps up its production. The firm has stated that its intention is to dedicate enough manufacturing lines to produce free hand sanitizers for Oahu’s first responders.

Data from the Department of Health’s Medical Cannabis Registry Program shows that the average age of registered medical cannabis patients in Hawaii is approximately 52. Most of them have underlying medical conditions including cancer, HIV/AIDS, epilepsy, and Multiple Sclerosis, making them especially vulnerable to Covid-19.

“All our locations have a supply of hand sanitizer solution for employee and patient use. We have increased our sanitation procedures. Due to recent reports of hoarding, outages and low supplies in Hawaii, we have decided to manufacture and provide bottles of hand sanitizer free of charge to vulnerable patients who are at increased risk,” says Aloha Green Apoth spokesman TY Cheng.

Aloha Green Apoth CEO James Lee adds that “supporting our local community is a foundational goal for our company. Our cannabis medicines provide essential relief for many patients and we hope patients will continue to feel safe at our dispensaries.”

The firm reminds people that although using a 60%-plus alcohol-based solution is effective, health authorities say that using soap and water is still the most effective method to clean your hands and avoid infection.

Experts say the example set by Aloha Green Apothecary is one that paints the entire cannabis industry, including Champignon Brands Inc. (CSE: SHRM), in good light as sector players are seen as going above and beyond to be helpful to the communities they serve.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Champignon Brands (CSE: SHRM), a wellness company specializing in medicinal mushroom and mushroom-infused products, today announced the broadcast of its audio interview with NetworkNewsAudio (“NNA”), one of 40+ brands in the InvestorBrandNetwork (“IBN”). In the interview, Champignon Brands CEO Gareth Birdsall joins NNW’s Stuart Smith to delve into the company’s strategic plan to expand its portfolio and become a preeminent player in the emerging psychedelic medicine arena. “We’ve achieved some pretty impressive sales from around the globe, revamped our e-commerce website, as well as commenced certain research and development initiatives,” Birdsall said, noting Champignon recently completed an initial public offering and is planning to achieve listings in Frankfurt, Germany and on the OTC marketplace in the U.S.

To view the full press release, visit http://cnw.fm/0pPyx

About Champignon Brands Inc.

Champignon Brands Inc. (CSE: SHRM) is a Canadian based company dedicated to the distribution of artisanal medicinal mushrooms infused products. The Champignon team is mandated with enhancing the health and wellness of millions of potential consumers through the distribution of a premium, mushroom-infused product suite. Champignon continues to be inspired by sustainability, as all of its eligible SKUs are organic, non-GMO and vegan certified. For more information, visit www.Champignonbrands.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://cnw.fm/SHRM

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

Champignon Brands (CSE: SHRM), a wellness company specializing in medicinal mushroom and mushroom-infused products, today announced its intent to commence a normal course issuer bid (“NCIB”) to purchase up to a total of 2,411,883 common shares, representing 5% percent of the issued and outstanding common shares of the company as of March 20, 2020. Per the news release, Champignon believes that current market conditions have resulted in its shares being undervalued relative to the immediate and long-term value of its vertically integrated portfolio of alternative medicine products. Pursuant to the NCIB, the company may purchase the common shares through the facilities of the Canadian Securities Exchange (“CSE”) and/or alternative trading systems, at various times over the next 12 months if considered advisable. Purchases may commence through the CSE and/or alternative trading systems on March 27, 2020 and will conclude on either the date on which purchases under the bid have been completed or on March 27, 2021, whichever comes first. All common shares purchased by the company will be cancelled. The company appointed PI Financial Corp. to coordinate and facilitate its NCIB purchases.

To view the full press release, visit http://cnw.fm/2prTX

About Champignon Brands Inc.

Champignon Brands Inc. (CSE: SHRM) is a Canada-based company dedicated to the distribution of artisanal medicinal mushrooms infused products. The Champignon team is mandated with enhancing the health and wellness of millions of potential consumers through the distribution of a premium, mushroom-infused product suite. Champignon continues to be inspired by sustainability, as all of its eligible SKUs are organic, non-GMO and vegan certified. For more information, visit the company’s website at www.Champignonbrands.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://cnw.fm/SHRM

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

It’s official, the novel Coronavirus is now a pandemic. The virus first appeared in Wuhan, China at the close of 2019, and as of now, over 180,000 people have been infected. As the virus swept through China, to Europe, the U.S. and finally Africa, one thing has been pretty clear. Things will get worse before they get better, and recognizing that fact, the World Health Organization (WHO) raised the virus’s threat level.

The loss of life has been immense, with the virus leaving over 4,000 people dead. The fact that it is extremely communicable hasn’t helped, and numerous governments have had to order lockdowns to curb its spread. This, however, has wreaked havoc on the world economy, and experts say the situation will only get worse. The cannabis industry hasn’t been spared either. For starters, it has been subject to the following;

Supply Chain Disruptions. China was hit hard by the virus, and numerous regions effectively went into shutdown mode. And since China is a low-cost producer, the effects have been felt across a lot of industries. The vaping segment, for instance, relies heavily on China for parts, and a lot of firms have found themselves running out of supplies with no avenues for replenishment.

A large portion of growing equipment such as heating, ventilation, air conditioning products, and LED bulbs also come from China.

Canceled trade shows. For an industry as young as the cannabis sector, trade shows are one of the few places firms can show off their products and network. However, these shows are often attended by thousands of people, and while that’s awesome when you’re looking for buyers or investors, it is a liability in the times.  For instance, the CannaTech Medical Cannabis Innovation Conference was postponed until June 15-16, while the Natural Products Expo West was postponed indefinitely.

Reduced Tourism. One of the first responses to the Coronavirus was limiting flights to affected countries. However, as the virus spread, more and more countries started closing their borders. This, coupled with the lockdown and self-isolation orders, has severely impacted the tourism sector. Cities like Las Vegas rely heavily on tourism, and cannabis stores like Planet 13 Holdings are sure to see reduced sales in the coming weeks.

Major lockdowns and quarantines may be down the road if the virus keeps spreading. Countries like Italy are a good example of how things might turn out, and this won’t be good for most businesses. And if more people and infected and forced to self-quarantine, it could lead to a shutdown of most retail shops except the most essential ones.

At the moment, the best we can do is hunker down, take the proper precautions and wait the pandemic out. Industry actors like Champignon Brands Inc. (CSE: SHRM) may be hoping that the pandemic quickly comes to an end given that the marijuana industry already had its own growing pains.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Champignon Brands (CSE: SHRM), a wellness company specializing in medicinal mushroom and mushroom-infused products, today announced the expansion of its vertically integrated, alternative medicine product portfolio with the addition of new proprietary intellectual property (“IP”). SHRM recently entered into a definitive agreement, signed March 18, 2020, to acquire Novo Formulations Ltd. (“Novoformulations”), a specialty biotechnology company focused on developing novel and innovative delivery systems for the pharmaceutical and nutraceutical industries. Per the terms of the agreement, Champignon will acquire 100% of the issued and outstanding shares of Novoformulations for a total consideration of 12.5 million common shares in the capital of the company at a deemed price of $0.2475 each. A finder’s fee is also applicable to this transaction. The Novoformulations team is comprised of skilled PhDs and technician level scientists presently working with ketamine, anaesthetics and adaptogenics, as well as various pharmaceuticals and natural molecules. Champignon aims to leverage Novoformulations’ existing product development infrastructure and licensed affiliates to pursue psilocybin and MDMA based formulations, with the goal of developing and commercializing rapid onset treatments with the potential of improving health outcomes, including depression, PTSD and substance and alcohol use disorders (“DPS”). “The existing infrastructure inherited from these recent acquisitions positions us as a leading participant throughout the entire alternative medicine lifecycle, from R&D to formulation, manufacturing and end distribution. The end result will be a turnkey solution that incorporates both standardized ingredient mixtures and pharmaceutical grade products that can now be marketed via a variety of proprietary delivery systems,” Champignon CEO Gareth Birdsall stated in the news release. “The addition of Novoformulations allows Champignon to deliver medications in a safer, more effective and more expeditious manner than our peers, from bench top in the laboratory, to preclinical and clinical trials. We are intent on the commercialization of products throughout North America, as rapidly as is safely and effectively practicable.”

To view the full press release, visit http://cnw.fm/ty8tF

About Champignon Brands Inc.

Champignon Brands Inc. (CSE: SHRM) is a Canada-based company dedicated to the distribution of artisanal medicinal mushrooms infused products. The Champignon team is mandated with enhancing the health and wellness of millions of potential consumers through the distribution of a premium, mushroom-infused product suite. Champignon continues to be inspired by sustainability, as all of its eligible SKUs are organic, non-GMO and vegan certified. For more information, visit the company’s website at www.Champignonbrands.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://cnw.fm/SHRM

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

Ten years ago, the thought of states legalizing marijuana seemed ludicrous enough. The plant has always been quite divisive, with most people being either for or against marijuana. However, what’s certain is that marijuana does have plenty of medicinal properties that make it a good natural alternative to a variety of medications including opioids.

The past few years have seen cannabis become more mainstream, with a number of states legalizing it for both recreational and medical use. Alabama quite recently joined the club after the state Senate voted to pass a bill to legalize marijuana in the state. The bill would allow qualifying patients to purchase certain medical marijuana products from state-licensed dispensaries.

It would also prohibit cannabis for smoking or vaping, with only tablets, topicals, and certain cannabis-infused edibles being legally available for sale.

“I think in this day and time, with the opioid crisis, we need to try alternative medicines that will help people,” says Sen. David Sessions, who voted to pass the bill. The proposal now heads to the House, and it’s sure to be a nail biter. Speaker McCutcheon has been non-committal, stating last month that he’s in ‘wait and see mode.’

Dubbed SB 165, the bill would establish a state Medical Cannabis Commission to register patients and oversee licensing businesses. Patients suffering from qualifying conditions such as anxiety, cancer, epilepsy, and post-traumatic stress disorder will be eligible for the program. They will be able to purchase up to a 70-day supply of medical marijuana products at a time.

The bill also sets a cap of 32 dispensaries allowed in the state, and the products they sell will be tested for potency and contaminants. Sales from the licensed dispensaries will be subject to a 9% tax, and part of those funds will be used to create a new Consortium for Medical Cannabis Research that will provide grants to study cannabis.

Under the proposal, medical marijuana will be tracked from seed to sale, and workers at the cannabis facilities will be subject to background checks.

“Today’s landslide vote in the Alabama Senate shows lawmakers in even the most conservative states in the nation are starting to recognize that allowing medical cannabis is good politics and good policy. Voters of every political background overwhelmingly support allowing medical cannabis,” says Karen O’Keefe, state policies director for the Marijuana Policy Project.

“That said, with polls showing upwards of 90% of Americans support allowing medical marijuana, it’s alarming that 27 states continue to criminalize patients for choosing a safer alternative to opioids.”

It remains to be seen what established companies like Champignon Brands Inc. (CSE: SHRM) think advocates should do to win support from the lawmakers in the House who aren’t in support of the legislation.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Champignon Brands (CSE: SHRM), a wellness company specializing in medicinal mushroom and mushroom-infused products, continues to advance its vertical integration through the addition of craft mushroom production, manufacturing and research capabilities. On Friday, the Company announced its entry into a definitive agreement to acquire Artisan Growers Ltd., a British Columbia based craft mushroom cultivator and supplier. Artisan Growers utilizes a variety of techniques and infrastructure to produce premium craft mushrooms, operating a craft cultivation facility capable of producing an assortment of organic varietals including Lion’s Mane, Chaga, Reishi and Agaricus Blazei. According to the update, Champignon plans to integrate Artisan Growers’ craft mushroom production capacity into its existing medicinal mushroom manufacturing, formulation and distribution infrastructure in continued control of its supply chain directly to the end user. “With the acquisition of Artisan Growers, we continue to optimize our upstream, downstream and distribution capabilities, all the while securing valuable infrastructure to expedite our R&D pursuits,” Champignon Brands Chief Executive Officer Gareth Birdsall said in the news release. “Over the coming quarters we will tactically execute on our stated business plan and look to also emerge as a best-in-class vertically integrated medicinal mushroom extract formulator, integrating alternative medicine, clinical research and vocational rehabilitation into the Company’s current product portfolio.”

To view the full press release, visit http://cnw.fm/ktz4J

About Champignon Brands Inc.

Champignon Brands has positioned itself to rapidly become a global force as a vertically integrated producer of artisanal medicinal mushrooms and associated products. The Champignon team is focused on enhancing the health and wellness of millions of consumers who can benefit from its premium suite of organic, sustainable and non-GMO mushroom and mushroom-infused formulations. For more information, visit www.Champignonbrands.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://cnw.fm/SHRM

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com